Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.6.1.7 - acylphosphatase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Alzheimer Disease
Alteration of acylphosphatase levels in familial Alzheimer's disease fibroblasts with presenilin gene mutations.
Changes in Na+,K(+)-ATPase, Ca2(+)-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease.
Brain Neoplasms
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma.
Breast Neoplasms
Arabidopsis C-terminal domain phosphatase-like 1 and 2 are essential Ser-5-specific C-terminal domain phosphatases.
Genetic variants in the acylphosphatase 2 gene and the risk of breast cancer in a Han Chinese population.
Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women.
Carcinogenesis
Assessment of the association between ACYP2 and laryngeal squamous cell carcinoma risk in Chinese males.
Carcinoma
Assessment of the association between ACYP2 and laryngeal squamous cell carcinoma risk in Chinese males.
Leukocyte telomere length-related genetic variants in ACYP2 contribute to the risk of esophageal carcinoma in Chinese Han population.
Carcinoma, Renal Cell
Association between ACYP2 polymorphisms and the risk of renal cell cancer.
Colorectal Neoplasms
Genetic polymorphisms in the telomere length-related gene ACYP2 are associated with the risk of colorectal cancer in a Chinese Han population.
The expression of acylphosphatase is associated with the metastatic phenotype in human colorectal tumors.
The influence of ACYP2 polymorphisms on gastrointestinal cancer susceptibility in the Chinese Han population.
Diabetes Mellitus
Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer.
Gastrointestinal Neoplasms
The influence of ACYP2 polymorphisms on gastrointestinal cancer susceptibility in the Chinese Han population.
Glioma
ACYP2 contributes to malignant progression of glioma through promoting Ca2+ efflux and subsequently activating c-Myc and STAT3 signals.
The effects of gene polymorphisms on glioma prognosis.
Hearing Loss
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities.
Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma.
Hyperthyroidism
Increased acylphosphatase levels in erythrocytes from hyperthyroid patients.
Infertility
The acylphosphatase (Acyp) alleles associate with male hybrid sterility in Drosophila.
Infertility, Male
The acylphosphatase (Acyp) alleles associate with male hybrid sterility in Drosophila.
Ischemic Stroke
Association of ACYP2 and TSPYL6 Genetic Polymorphisms with Risk of Ischemic Stroke in Han Chinese Population.
Leukemia
Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers.
Leukemia, Erythroblastic, Acute
Acylphosphatase is involved in differentiation of K562 cells.
Leukemia, Lymphoid
Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.
Liver Neoplasms
Associations between polymorphisms of the ACYP2 gene and Liver cancer risk: A case-control study and meta-analysis.
Lung Neoplasms
Association of polymorphisms in the telomere-related gene ACYP2 with lung cancer risk in the Chinese Han population.
Muscular Diseases
Acylphosphatase from human skeletal muscle: purification, some properties and levels in normal and myopathic muscles.
Muscular Dystrophies
Acylphosphatase from human skeletal muscle: purification, some properties and levels in normal and myopathic muscles.
Muscular Dystrophy, Duchenne
Sarcoplasmic reticulum Ca2+-ATPase and acylphosphatase activities in muscle biopsies from patients with Duchenne muscular dystrophy.
Neoplasms
Association between ACYP2 polymorphisms and the risk of renal cell cancer.
Associations between polymorphisms of the ACYP2 gene and Liver cancer risk: A case-control study and meta-analysis.
Genetic polymorphisms in the telomere length-related gene ACYP2 are associated with the risk of colorectal cancer in a Chinese Han population.
The expression of acylphosphatase is associated with the metastatic phenotype in human colorectal tumors.
The influence of ACYP2 polymorphisms on gastrointestinal cancer susceptibility in the Chinese Han population.
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.
[ACETYLPHOSPHATASE IN TUMORS.]
Neuroblastoma
Acylphosphatase overexpression triggers SH-SY5Y differentiation towards neuronal phenotype.
Alteration of intracellular free calcium and acylphosphatase levels in differentiating SH-SY5Y neuroblastoma cells.
Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers.
Neurodegenerative Diseases
Oxadiazon affects the expression and activity of aldehyde dehydrogenase and acylphosphatase in human striatal precursor cells: A possible role in neurotoxicity.
Osteosarcoma
Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers.
Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma.
Ototoxicity
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study).
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study.
Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.
Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma.
The genetic vulnerability to cisplatin ototoxicity: a systematic review.
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.
Squamous Cell Carcinoma of Head and Neck
Assessment of the association between ACYP2 and laryngeal squamous cell carcinoma risk in Chinese males.
Stomach Neoplasms
Association analysis of telomere length related gene ACYP2 with the gastric cancer risk in the northwest Chinese Han population.
The influence of ACYP2 polymorphisms on gastrointestinal cancer susceptibility in the Chinese Han population.